Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. - Wikidata - awgldk - TriplyDB

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.

http://www.wikidata.org/entity/Q36168809

about

Non-alcoholic fatty liver disease: what the clinician needs to know.Gut microbiota and metabolic syndrome Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH Role of the microbiome in non-gastrointestinal cancers Bile acid receptors and nonalcoholic fatty liver disease Genetic background in nonalcoholic fatty liver disease: A comprehensive review Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?Kupffer cells in the liver Obesity, fatty liver disease and intestinal microbiota Role of innate immunity in the development of hepatocellular carcinoma Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver Toll-like receptors in pathophysiology of liver diseases Molecular Pathogenesis of NASH Obesity: An Immunometabolic Perspective Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver Disease The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease Metformin and metabolic diseases: a focus on hepatic aspects Gut Microbiota and Host Reaction in Liver Diseases NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury.TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH)Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease.Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.Western diet enhances hepatic inflammation in mice exposed to cecal ligation and puncture Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease Elevated endotoxin levels in non-alcoholic fatty liver disease.Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis Toll-like receptor 4 and hepatic fibrogenesis Steatosis and steatohepatitis: complex disorders.Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease.A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits Cyclic AMP-guanine exchange factor activation inhibits JNK-dependent lipopolysaccharide-induced apoptosis in rat hepatocytes.

P2860

Q24563068-2227EC4F-945D-4A30-B286-E0DA8F24B3C3 Q24563886-D9C6B2D7-1BCD-4F08-AD27-22FF1E4217A2 Q26742102-E7E6FB95-7A4A-4628-AD00-32DCB01E5505 Q26747710-9FEC9120-4630-47C5-9414-AC712C323CDA Q26775814-B51A3F80-4199-497F-A9A3-08B4EF96BE97 Q26780248-DFE62AE5-978E-41FA-B2AA-51CCEB95CA20 Q26798033-F3295361-DEBF-4579-8F27-5468E14E0EC4 Q26822031-065B0FFC-30B7-4CEC-B6F6-22825B30548A Q26997784-BF3BADCC-0F6E-4775-B059-49561C5EFC98 Q27024780-5BEADDCC-391B-4801-9A49-240A07C1EB2C Q27330629-E7AAC64E-387E-4784-A2A8-B438793B812A Q27334969-2BC60A59-E942-4D9F-9562-21BB3CE098DA Q28070077-0C2C497E-B54C-4A8C-A9DC-3FF6011BE084 Q28071265-B37F6E13-D613-44EB-8625-1C22AB1906BD Q28072140-A9056456-8318-46A9-BA81-99075F6E9557 Q28078342-54725416-B697-4875-BEAE-7CFEC44AA32A Q28078754-2910CEE5-B428-4E29-A0EC-532EF7AD0627 Q28082736-77FD97BE-5B6F-41F1-8E15-DA731B7D8520 Q28083295-18D65E66-2A6B-4EB8-AD07-46980E206E67 Q28384956-F933D0F0-AD3F-4A21-BBDC-D477D1531F41 Q28512778-40D9226F-0C1E-498F-B8B2-E68187322141 Q28748743-F48FD13D-6503-46FB-A767-5CA1B6530A6E Q30375693-EAA11704-3D72-43EB-AE65-659014AE057E Q30983737-AB32A688-F74D-4B67-83BD-B7A8F98E8C58 Q33428592-0F5555FC-6E4E-4DEC-980F-553EBD898908 Q33600346-C8DCB2F5-95C2-4890-A253-DEE7995DD851 Q33665070-C93F4411-3021-4866-9703-40D5E986CC22 Q33709456-1E3AF321-EF6E-473E-AD11-022A0959D664 Q33714116-47CCAEE8-D510-4FBC-9B0D-EEA2BB85AF22 Q33722712-F217B146-3360-4F8C-8C25-6576F9B3AC39 Q33755829-249128E2-2BBE-419A-B6FB-B274067BF4FB Q33780172-9723FA5F-A43D-4203-8F03-9DDE4CC2A369 Q33864406-967DDD76-DBB5-430D-8FAD-FAE2615DE240 Q33870766-C579C330-2CFA-4007-AE45-966D1B5874F4 Q33898945-C0DFD886-3B1E-4F4A-AF32-F192C32D2544 Q33905721-972FB50B-565E-43DC-AD7E-B5398A481E2A Q33907632-A422BF5B-CCE1-418F-A36E-6B4A7122B0D7 Q33926022-DCE6A2B0-80A6-43B0-85B4-C8777BB9DA67 Q33947195-15A73AC9-E46D-4102-B7C7-1DD8BF8D6627 Q33956944-889256F8-080F-42E2-AF1D-6898E63404EE

P2860

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.

http://www.wikidata.org/entity/Q36168809

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Toll-like receptor-4 signaling ...... non-alcoholic steatohepatitis.

@ast

Toll-like receptor-4 signaling ...... non-alcoholic steatohepatitis.

@en

type

label

Toll-like receptor-4 signaling ...... non-alcoholic steatohepatitis.

@ast

Toll-like receptor-4 signaling ...... non-alcoholic steatohepatitis.

@en

prefLabel

Toll-like receptor-4 signaling ...... non-alcoholic steatohepatitis.

@ast

Toll-like receptor-4 signaling ...... non-alcoholic steatohepatitis.

@en

P1433

Q36168809-6ACB73DA-5C73-4C65-9CD5-3FF2CDCB64CF

P1476

Q36168809-898A6E25-4682-42C4-A66C-59722189ADB9

P2093

Q36168809-6E4DA7B2-3FF4-4B1F-9E3F-D467E4CCAD39

Q36168809-8061F52F-AB3F-448B-BDAF-D554B7F6DF45

Q36168809-A23A04B9-F632-485A-823B-8C3C8A59927B

Q36168809-B2D792AE-9F27-4672-A91C-6E7840CA5F06

Q36168809-BE704D39-D975-4D19-A620-F73DD9BAC324

P2860

Q36168809-2776435C-6CE3-4E9C-84FB-0A8DE167AB07

Q36168809-2AFE828F-4883-4105-87D4-5AA7B0745920

Q36168809-2D5B639A-FDE2-4DD3-BEAC-412F26A1A999

Q36168809-300DEB4A-5A4F-4AAE-A083-7EA13868BC47

Q36168809-3804268F-5343-46FB-B4C4-41D213A0BB7F

Q36168809-3EC2A907-E3BB-4B68-BA07-4DBA830400FA

Q36168809-3F8CCF6E-F848-485D-9F65-842C0B68EB6E

Q36168809-4A7094D6-EEF5-409B-954B-10EA0BB3225D

Q36168809-4ABF21EB-6417-4F77-B8C0-DFB39C0035EB

Q36168809-57285F66-B62D-49DF-980E-9159BB80C5F8

P304

Q36168809-339885C7-0F1E-4964-84AA-EBE451455642

P31

Q36168809-EECB3483-7E3D-46FD-8D09-873D6066FDA7

P356

Q36168809-BB18B2BE-6F90-4896-A22C-F5A5D644D84D

P433

Q36168809-B044EEAB-40BD-4397-932F-094D9B360353

P478

Q36168809-CF40C4C1-30CC-47E4-8F3F-8279FF1B3B7C

P50

Q36168809-DF5D6E62-4AD8-4D41-BE4D-1A594D3F4861

P577

Q36168809-C2FB324E-310F-4217-9CBA-E8191091D5B1

P5875

Q36168809-55521544-F7E1-4958-A9D0-BC2EAD8BA017

P698

Q36168809-AA38D50E-18C2-47CB-8A79-18DC9D85053F

P921

Q36168809-19F7331C-64D8-44A3-B60B-5626AEDCC6E8

Q36168809-8DA57FA3-4FE1-4A81-AB4F-9E4BA610C28E

Q36168809-FDC08D79-1225-4676-B623-C244372B81CE

P932

Q36168809-70CCC00B-A63C-4CBD-A59A-71E97549F09B

P356

J.JHEP.2007.04.019

P1433

Journal of Hepatology

P1476

Toll-like receptor-4 signaling ...... non-alcoholic steatohepatitis.

@en

P2093

Arlene Tagalicud

http://www.w3.org/2001/XMLSchema#string

Chantal A Rivera

http://www.w3.org/2001/XMLSchema#string

Matthew Wallace

http://www.w3.org/2001/XMLSchema#string

Monique Allman

http://www.w3.org/2001/XMLSchema#string

Patrick Adegboyega

http://www.w3.org/2001/XMLSchema#string

P2860

Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components

CD36 is a sensor of diacylglycerides

Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2

Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism.

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

Biologically active products of stimulated liver macrophages (Kupffer cells).

Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation.

Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.

P304

571-579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2007.04.019

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Nico van Rooijen

P577

2007-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6194831

http://www.w3.org/2001/XMLSchema#string

P698

17644211

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

Toll-like receptor

P932

2094119

http://www.w3.org/2001/XMLSchema#string